SXTP
NASDAQ · Pharmaceuticals
60 Degrees Pharma Inc
$0.59
-0.32 (-35.08%)
Open$0.67
Previous Close$0.92
Day High$0.67
Day Low$0.55
52W High$8.62
52W Low$0.59
Volume—
Avg Volume1.91M
Market Cap2.09M
P/E Ratio—
EPS$-5.93
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+347.1% upside
Current
$0.59
$0.59
Target
$2.66
$2.66
$2.13
$2.66 avg
$3.16
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 7.39M | 5.27M | 862.6K |
| Net Income | -38,649,233 | -24,808,722 | 198.9K |
| Profit Margin | -522.7% | -496.6% | 23.1% |
| EBITDA | -40,486,507 | -27,431,839 | 334.7K |
| Free Cash Flow | — | — | 224.8K |
| Rev Growth | +40.2% | +40.2% | -6.7% |
| Debt/Equity | 0.04 | 0.04 | 0.52 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |